Abstract: . . .  glomeru- lar injury. J Am Soc Nephrol 1990; 1: S21-S27. 11. der Wee P, De Micheli AG, Epstein M. Effects of calcium antagonists on renal hemodynamics and progression of nondiabetic chronic renal disease. Arch Intern Med 1994; 154: 1185-1202. 12. Bakris GL, Barnhill BW, Sadler R. Treatment of arterial hypertension in dia- betic humans: importance of therapeutics selection. Kidney Int 1992; 41: 912-919. 13. Davis BR, Furberg CD, Wright JT et al. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. The anti- hypertensive and lipid-lowering treatment to prevent . . .
. . .  rate and proteinuria. Kidney Int 1990; 38: 590- 594. 10. Dworkin LD. Effects of calcium channel blockers on experimental glomeru- lar injury. J Am Soc Nephrol 1990; 1: S21-S27. 11. der Wee P, De Micheli AG, Epstein M. Effects of calcium antagonists on renal hemodynamics and progression of nondiabetic chronic renal disease. Arch Intern Med 1994; 154: 1185-1202. 12. Bakris GL, Barnhill BW, Sadler R. Treatment of arterial hypertension in dia- betic humans: importance of therapeutics selection. Kidney Int 1992; 41: 912-919. 13. Davis BR, Furberg CD, Wright JT et al. Major cardiovascular events in  . . .
. . .  proteinuria. Kidney Int 1990; 38: 590- 594. 10. Dworkin LD. Effects of calcium channel blockers on experimental glomeru- lar injury. J Am Soc Nephrol 1990; 1: S21-S27. 11. der Wee P, De Micheli AG, Epstein M. Effects of calcium antagonists on renal hemodynamics and progression of nondiabetic chronic renal disease. Arch Intern Med 1994; 154: 1185-1202. 12. Bakris GL, Barnhill BW, Sadler R. Treatment of arterial hypertension in dia- betic humans: importance of therapeutics selection. Kidney Int 1992; 41: 912-919. 13. Davis BR, Furberg CD, Wright JT et al. Major cardiovascular events in hypertensive . . .
. . .  role of prostaglandins in human hypertension . Am J Kidney Dis 1985; 5: A32-A39. 7. Blaine EH. Role of atriopeptin in blood pressure regulation. Am J Med Sci 1988; 31: 293-298. 8. Vallance P, Lecne A, Calver A et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-575. 9. Rodicio JL, Alcazar JM, Ruilope LM. Influence of converting enzyme inhibi- tion on glomerular filtration rate and proteinuria. Kidney Int 1990; 38: 590- 594. 10. Dworkin LD. Effects of calcium channel blockers on experimental glomeru- lar injury. J Am Soc Nephrol . . .
--2605,4,326,2919,13025